| HealthPartners | Pompe disease enzyme replacement therapy: | 2025-10-01 |
| HealthPartners | Satralizumab-mwge (Enspryng™) and inebilizumab- | 2025-10-01 |
| HealthPartners | Satralizumab-mwge (Enspryng™) and inebilizumab- | 2025-10-01 |
| HealthPartners | Sebelipase alfa (Kanuma®) | 2025-10-01 |
| HealthPartners | Sebelipase Alfa (Kanuma®) – Minnesota Health Care | 2025-10-01 |
| HealthPartners | Spesolimab-sbzo (Spevigo®) | 2025-10-01 |
| HealthPartners | Statin medications for prevention of cardiovascular | 2025-10-01 |
| HealthPartners | Type I Gaucher disease intravenous enzyme | 2025-10-01 |
| HealthPartners | Type I Gaucher disease intravenous enzyme | 2025-10-01 |
| HealthPartners | Viltolarsen (Viltepso®) | 2025-10-01 |